Thompson KM - Search Results

1

Good news for billions of children who will receive IPV.

Thompson KM. Thompson KM. Lancet Infect Dis. 2015 Oct;15(10):1120-1122. doi: 10.1016/S1473-3099(15)00099-7. Epub 2015 Aug 16. Lancet Infect Dis. 2015. PMID: 26289957 No abstract available.

2

The potential impact of expanding target age groups for polio immunization campaigns.

Duintjer Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM. Duintjer Tebbens RJ, et al. Among authors: thompson km. BMC Infect Dis. 2014 Jan 29;14:45. doi: 10.1186/1471-2334-14-45. BMC Infect Dis. 2014. PMID: 24472313 Free PMC article.

3

Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine.

Thompson KM. Thompson KM. Lancet. 2014 Oct 25;384(9953):1480-2. doi: 10.1016/S0140-6736(14)60983-1. Epub 2014 Jul 10. Lancet. 2014. PMID: 25018123 No abstract available.

4

Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.

Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. J Infect Dis. 2014 Nov 1;210 Suppl 1:S398-411. doi: 10.1093/infdis/jit844. J Infect Dis. 2014. PMID: 25316861

5

Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.

Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. J Infect Dis. 2014 Nov 1;210 Suppl 1:S412-23. doi: 10.1093/infdis/jit834. J Infect Dis. 2014. PMID: 25316863

6

Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination.

Kisjes KH, Duintjer Tebbens RJ, Wallace GS, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM. Kisjes KH, et al. Among authors: thompson km. J Infect Dis. 2014 Nov 1;210 Suppl 1(Suppl 1):S424-33. doi: 10.1093/infdis/jit843. J Infect Dis. 2014. PMID: 25316864 Free PMC article.

7

Modeling the dynamics of oral poliovirus vaccine cessation.

Thompson KM, Duintjer Tebbens RJ. Thompson KM, et al. J Infect Dis. 2014 Nov 1;210 Suppl 1:S475-84. doi: 10.1093/infdis/jit845. J Infect Dis. 2014. PMID: 25316870

8

Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.

Duintjer Tebbens RJ, Thompson KM. Duintjer Tebbens RJ, et al. Among authors: thompson km. J Infect Dis. 2014 Nov 1;210 Suppl 1:S485-97. doi: 10.1093/infdis/jit838. J Infect Dis. 2014. PMID: 25316871

9

Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.

Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SG, Pallansch MA, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. J Infect Dis. 2015 Jun 1;211(11):1800-12. doi: 10.1093/infdis/jiu674. Epub 2014 Dec 10. J Infect Dis. 2015. PMID: 25505296 Free PMC article.

10

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.

Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. BMC Infect Dis. 2015 Feb 18;15:66. doi: 10.1186/s12879-015-0791-5. BMC Infect Dis. 2015. PMID: 25886823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page